Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q1
ECOLAB INC. for ECOLAB INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Environment/Superfund, Taxation/Internal Revenue Code, Trade (domestic/foreign), Energy/Nuclear
View →
Q1
WILLIAMS AND JENSEN, PLLC for SYNEOS HEALTH, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $30,000.00 income
Medical/Disease Research/Clinical Labs, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
WILLIAMS AND JENSEN, PLLC for NOVOCURE INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Hampshire · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q1
FOLEY & LARDNER LLP for FOUNDATION CONSUMER HEALTHCARE LLC
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $120,000.00 income
Pharmacy, Health Issues
View →
Q1
WILLIAMS AND JENSEN, PLLC for MERCK & CO INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Pharmacy
View →
Q1
MR. DAVID FRIEDMAN for TEVA PHARMACEUTICALS USA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · $250,000.00 income
Manufacturing, Pharmacy
View →
Q1
WILLIAMS AND JENSEN, PLLC for ELI LILLY & COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q1
WILLIAMS AND JENSEN, PLLC for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Pharmacy
View →
Q1
THE PROCTER AND GAMBLE COMPANY for THE PROCTER AND GAMBLE COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy, Health Issues, Trade (domestic/foreign), Consumer Issues/Safety/Products
View →
Q1
WILLIAMS AND JENSEN, PLLC for BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $80,000.00 income
Health Issues, Trade (domestic/foreign), Medicare/Medicaid, Manufacturing
View →
Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q1
WILLIAMS AND JENSEN, PLLC for ABBVIE, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Pharmacy
View →
Q1
FORBES-TATE for INDEPENDENT PHARMACY COOPERATIVE
1st Quarter (Jan 1 - Mar 31) 2026 · Wisconsin · House · Senate · $40,000.00 income
Health Issues, Pharmacy, Medicare/Medicaid, Budget/Appropriations
View →
1A
BGR GOVERNMENT AFFAIRS for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q1
TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Defense, Pharmacy
View →
Q1
JEFFREY J. KIMBELL & ASSOCIATES, INC. for ORCHARD THERAPEUTICS NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $10,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Copyright/Patent/Trademark, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs
View →
1A
BGR GOVERNMENT AFFAIRS for NEUROCRINE BIOSCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
BGR GOVERNMENT AFFAIRS for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
AARP for AARP
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Transportation
View →
Q1
HALEON US HOLDINGS LLC for HALEON US HOLDINGS LLC
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Environment/Superfund, Foreign Relations, Consumer Issues/Safety/Products, Copyright/Patent/Trademark
View →
Q1
LMH STRATEGIC SOLUTIONS for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $230,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q1
JAMES P. KEESE for NATIONAL ORGANIZATION OF RARE DISORDERS, INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $150,000.00 income
Health Issues, Pharmacy
View →
Previous Page 5 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem